CD86 and cancer: Because the reduction of Ikaros and EZH2 impact cancer cell growth and increase recognition of infected cells by the host immune system through increased ICAM-1 and B7-2, Pom may have both a direct and an indirect effect on the survival of HTLV-1-infected cells.